biomodal (formerly known as Cambridge Epigenetix) commercially launches its new duet multiomics solution, revealing the combinatorial power of genetic and.
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human HealthCAMBRIDGE, United Kingdom, June
Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
The automated workflows will use the Robotic Biology Institute's LabDroid to support whole-genome sequencing, targeted sequencing, and RNA isoform sequencing.